You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis
|
|---|---|
| Published in |
Arthritis Research & Therapy, March 2012
|
| DOI | 10.1186/ar3763 |
| Pubmed ID | |
| Authors |
Marie Hudson, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG), Marvin J Fritzler |
| Abstract |
Autoantibodies to Ro52 recently identified as TRIM21 are among the most common autoantibodies in systemic autoimmune rheumatic diseases, but their clinical association remains poorly understood. We undertook this study to determine the clinical and serologic associations of anti-Ro52/TRIM21 antibodies in patients with systemic sclerosis (SSc). |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Germany | 1 | 1% |
| Unknown | 83 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 11 | 13% |
| Researcher | 10 | 12% |
| Student > Ph. D. Student | 8 | 9% |
| Professor > Associate Professor | 7 | 8% |
| Student > Master | 7 | 8% |
| Other | 24 | 28% |
| Unknown | 18 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 44 | 52% |
| Agricultural and Biological Sciences | 11 | 13% |
| Immunology and Microbiology | 4 | 5% |
| Biochemistry, Genetics and Molecular Biology | 3 | 4% |
| Mathematics | 2 | 2% |
| Other | 2 | 2% |
| Unknown | 19 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 January 2021.
All research outputs
#16,722,913
of 25,374,917 outputs
Outputs from Arthritis Research & Therapy
#2,443
of 3,380 outputs
Outputs of similar age
#107,384
of 168,392 outputs
Outputs of similar age from Arthritis Research & Therapy
#32
of 59 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,380 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.2. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 168,392 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 34th percentile – i.e., 34% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.